Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Keen Eye Technologies logo — AI platform elevates pathology for drug development and diag...

Keen Eye Technologies

AI platform elevates pathology for drug development and diagnostics, supporting all stages and organ classes.

Founded 2015 Series A Total: $7.50M AI, Biotechnology +3

General Information

Company Name Keen Eye Technologies
Founded Year 2015
Industries AI, Biotechnology, Health Care +2
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Keen Eye Technologies. To contact Keen Eye Technologies, visit keeneye.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Keen Eye Technologies compare?

A PDF of Keen Eye Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Keen Eye Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Keen Eye Technologies

Keen Eye Technologies is an AI platform company in the biotechnology and healthcare industries, with a focus on elevating pathology for drug development and diagnostics. Their slogan, "AI platform elevates pathology for drug development and diagnostics, supporting all stages and organ classes," captures the essence of their mission. Founded in 2015, the company received a €6.00M Series A investment on 29 April 2019 from CM-CIC Capital Finance. As an AI platform provider, Keen Eye Technologies plays a crucial role in enhancing computational pathology to facilitate superior drug development and diagnostics. They cover the entire spectrum of drug development, from preclinical phases to clinical assay development. Their technology is adaptable and agile, catering to tissue samples from any organ class and therapeutic area. This recent investment signifies a vote of confidence in the potential of Keen Eye Technologies, and it positions the company for further growth and innovation in the field of AI-powered pathology for drug development and diagnostics.

Business keywords: AI platform, computational pathology, drug development, diagnostics, preclinical phase, clinical assay development, tissue analysis, organ class analysis, therapeutic area analysis

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €6.00M 1
CM-CIC Capital Finance
CM-CIC Capital Finance
29 Apr 2019
Seed Round €1.50M 1
Seventure Partners
Seventure Partners
12 Dec 2016

Keen Eye Technologies Alternatives & Competitors

View All Alternatives
Keen Eye Technologies vs
PredxBio
PredxBio United States

Reimagining Cancer Care with AI-Driven Spatial Biomarkers

Convertible Note
14 employees
AI, Biopharma
Keen Eye Technologies vs
Deciphex
Deciphex Ireland

Transforming Pathology using Tailored Workflows and Artificial Intelligence

Series C
174 employees
AI, Biotechnology
Keen Eye Technologies vs
OrganOmics
OrganOmics United States

Human Tissues for Human Therapeutics

Non Equity Assistance
2 employees
Biotechnology, Health Care
View all alternatives

FAQ About Keen Eye Technologies

AI platform elevates pathology for drug development and diagnostics, supporting all stages and organ classes.
Keen Eye Technologies was founded in 2015.
Keen Eye Technologies operates in AI, Biotechnology, Health Care, Medical Devices and Machine Learning. Its work centres on AI platform, computational pathology, drug development and diagnostics.
Keen Eye Technologies has completed 2 funding rounds, raising a total of $7.50M. The latest funding stage is Series A.
Top alternatives and competitors to Keen Eye Technologies include PredxBio, Deciphex, OrganOmics, PathAI, Aignostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Keen Eye Technologies and PredxBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Keen Eye Technologies, https://bouncewatch.com/company/keen-eye-technologies, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout